Kinome profiling identifies MARK3 and STK10 as potential therapeutic targets in uveal melanoma.

MLA

Baqai, Usman, et al. “Kinome Profiling Identifies MARK3 and STK10 as Potential Therapeutic Targets in Uveal Melanoma.” The Journal of Biological Chemistry, vol. 299, no. 12, Dec. 2023, p. 105418. EBSCOhost, https://doi.org/10.1016/j.jbc.2023.105418.

APA

Baqai, U., Kurimchak, A. M., Trachtenberg, I. V., Purwin, T. J., Haj, J. I., Han, A., Luo, K., Pachon, N. F., Jeon, A., Chua, V., Davies, M. A., Gutkind, J. S., Benovic, J. L., Duncan, J. S., & Aplin, A. E. (2023). Kinome profiling identifies MARK3 and STK10 as potential therapeutic targets in uveal melanoma. The Journal of Biological Chemistry, 299(12), 105418. https://doi.org/10.1016/j.jbc.2023.105418

Chicago

Baqai, Usman, Alison M Kurimchak, Isabella V Trachtenberg, Timothy J Purwin, Jelan I Haj, Anna Han, Kristine Luo, et al. 2023. “Kinome Profiling Identifies MARK3 and STK10 as Potential Therapeutic Targets in Uveal Melanoma.” The Journal of Biological Chemistry 299 (12): 105418. doi:10.1016/j.jbc.2023.105418.